ClinVar Miner

Submissions for variant NM_001165963.4(SCN1A):c.5273_5277del (p.Asn1758fs)

dbSNP: rs796053085
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000189066 SCV000242697 pathogenic not provided 2015-01-05 criteria provided, single submitter clinical testing c.5273_5277delACCCA: p.Asn1758IlefsX35 (N1758IfsX35) in exon 26 of the SCN1A gene (NM_001165963.1). The normal sequence with the bases that are deleted in braces is: GGGA{ACCCA}TCTG. The c.5273_5277delACCCA mutation in the SCN1A gene causes a frameshift starting with codon Asparagine 1758, changes this amino acid to an Isoleucine residue and creates a premature Stop codon at position 35 of the new reading frame, denoted p.Asn1758IlefsX35. This mutation is predicted to cause loss of normal protein function through protein truncation. Although this mutation has not been previously reported to our knowledge, other truncating mutations in the SCN1A gene have been reported in association with SCN1A-related disorders in an external mutation database. Therefore, the presence of c.5273_5277delACCCA is consistent with a diagnosis of an SCN1A-related disorder. The variant is found in INFANTV2-EPIV2-1 panel(s).
Labcorp Genetics (formerly Invitae), Labcorp RCV001857650 SCV002122036 pathogenic Early infantile epileptic encephalopathy with suppression bursts 2021-03-14 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with epilepsy and/or neurodevelopmental disorder (PMID: 29655203). ClinVar contains an entry for this variant (Variation ID: 206923). This variant disrupts the C-terminus of the SCN1A protein. Other variant(s) that disrupt this region (p.Ala1919Leufs*13) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Asn1758Ilefs*35) in the SCN1A gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 252 amino acid(s) of the SCN1A protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.